SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-133577
Filing Date
2022-04-29
Accepted
2022-04-29 16:07:04
Documents
5
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d242757ddef14a.htm DEF 14A 416040
2 GRAPHIC g242757g00j01.jpg GRAPHIC 138331
3 GRAPHIC g242757g00j02.jpg GRAPHIC 157781
4 GRAPHIC g242757g00s00.jpg GRAPHIC 27184
5 GRAPHIC g242757g02a25.jpg GRAPHIC 34484
  Complete submission text file 0001193125-22-133577.txt   907105
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40671 | Film No.: 22875265
SIC: 2834 Pharmaceutical Preparations